Cannabidiol as a novel therapeutic agent for patients at ultra-high risk of psychosis: an experimental medicine approach.

Project: Research

Project Details

StatusFinished
Effective start/end date2/01/20131/10/2015

Funding

  • MRC Medical Research Council: £376,857.00